Utility of (1–3)-β-d-Glucan Testing for Diagnostics and Monitoring Response to Treatment During the Multistate Outbreak of Fungal Meningitis and Other Infections
Open Access
- 12 December 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 58 (5), 622-630
- https://doi.org/10.1093/cid/cit808
Abstract
Background. The 2012 outbreak of fungal meningitis associated with contaminated methylprednisolone produced by a compounding pharmacy has resulted in >750 infections. An important question facing patients and clinicians is the duration of antifungal therapy. We evaluated (1-3)-β-d-glucan (BDG) as a marker for monitoring response to treatment. Methods. We determined sensitivity and specificity of BDG testing using the Fungitell assay, by testing 41 cerebrospinal fluid (CSF) specimens from confirmed cases of fungal meningitis and 66 negative control CSF specimens. We also assessed whether BDG levels correlate with clinical status by using incident samples from 108 case patients with meningitis and 20 patients with serially collected CSF. Results. A cutoff value of 138 pg/mL provided 100% sensitivity and 98% specificity for diagnosis of fungal meningitis in this outbreak. Patients with serially collected CSF were divided into 2 groups: those in whom BDG levels declined with treatment and those in whom BDG remained elevated. Whereas most patients with a decline in CSF BDG had clinical improvement, all 3 patients with continually elevated BDG had poor clinical outcomes (stroke, meningitis relapse, or development of new disease). Conclusions. Our data suggest that measuring BDG in CSF is a highly sensitive test for diagnosis of fungal meningitis in this outbreak. Analysis of BDG levels in serially collected CSF demonstrated that BDG may correlate with clinical response. Routine measurement of BDG in CSF may provide useful adjunctive data for the clinical management of patients with outbreak-associated meningitis.This publication has 22 references indexed in Scilit:
- Detection of Fungal DNA in Human Body Fluids and Tissues during a Multistate Outbreak of Fungal Meningitis and Other InfectionsEukaryotic Cell, 2013
- Diverse Lifestyles and Strategies of Plant Pathogenesis Encoded in the Genomes of Eighteen Dothideomycetes FungiPLoS Pathogens, 2012
- Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- The (1,3)β- d -Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung TransplantationJournal of Clinical Microbiology, 2010
- β‐Glucans and Dectin‐1Annals of the New York Academy of Sciences, 2008
- Cerebrospinal Fluid and Plasma (1→3)-β-d-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental HematogenousCandidaMeningoencephalitisAntimicrobial Agents and Chemotherapy, 2008
- Diagnostic value of DNA, (1-3)-β-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreusDiagnostic Microbiology and Infectious Disease, 2007
- Exserohilum: an emerging human pathogenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Immune recognition of fungal β-glucansCellular Microbiology, 2005
- -D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic SyndromeClinical Infectious Diseases, 2004